Conferences
Find out where our medical materials experts will be speaking in 2011.
2012
SMI Controlled Release Conference, London - 28-29 March 2012
Dr. Xiang Zhang, Principal Consultant, Medical Devices & Materials, will be giving a presentation on ‘New inorganic glass-ceramic controlled release technology for pharmaceutical applications’. Find out more about the Conference here.
World Drug Delivery & Forumulation Summit, Berlin - 16-18 January 2012
Dr. Xiang Zhang, Principal Consultant, Medical Devices & Materials, talked about our new ‘Inorganic Glass-Ceramic Controlled Release Technology for Pharmaceutical Applications’. Find out more about the summit and read the full programme here.
2011
Medtec, Cork, Ireland - 5-6 October 2011
Ben McCarthy, our Hydroxyapatite specialist, gave a talk on Surface Analysis Comparison of In-vitro Bioactivity Testing.
PSA 2001, Edinburgh - 5-7 September 2011
Dr. Phil Jackson, Business Development Manager, Healthcare gave a joint presentation with Dr. Robert Sayer, Croda Suncare & Biotechnology at PSA 2011. The talk entitled ‘The Use of Zeta Potential in Sun-screen Product Formulation’ discussed the successful work that Ceram and the team at Croda carried out in this area. Ceram attends this event every year in order to keep up-to-date with new analytical techniques.
EMDT Virtual Event - Developments in Materials for Medical Applications - 24 May 2011
Dr. Xiang Zhang gave a keynote speech at this virtual conference and trade show.
Eurobiomat, Jena, Germany - 13-14 April 2011
Dr. Xiang Zhang presented: New Development of Bioceramic Polymer Composites for Orthopaedic Applications.
Ben McCarthy presented: Synthesis and Characterisation of Multi-Substituted Hydroxyapatite.
Further information and abstracts of the above two presentations can be found on Eurobiomat’s website.
Medtec UK, Birmingham, UK - 6-7 April 2011
Dr. Xiang Zhang was part of the panel on Materials for Orthopaedics Devices. The panel will explore how to identify optimal materials that save time and money.
- Choices of materials for orthopaedics: metal, polymer, ceramic?
- Major concerns on metal, polymer, ceramic: advantages and disadvantages
- New concepts on bioactivity, biocompatibility and shelf‐life for younger patients
- Best practices to results: design and development for future orthopaedic materials
For further details and to view the full conference programme, visit the Medtec UK website.
Smi 8th Conference on Controlled Release, London - 30-31 March 2011
Dr. Xiang Zhang presented the following paper -
‘Bioglass and bioceramics as delivery vehicles for controlled-release’
- Why bioglass and bioceramics as alternatives to polymeric delivery system for controlled release?
- Advantages of employing bioglass and bioceramics over polymer systems
- Hybrid systems of polymer and bioglass/bioceramics as drug carriers for controlled release
- Case studies
- Future application: choices of delivery systems for controlled release
For further details on the event, visit their website.
Bio-Europe Spring 2011, Milan - 14-16 March 2011
Dr. Xiang Zhang gave a company presentation at this event, detailing Ceram’s latest materials innovation work.
For further details on the event, visit their website.
BIOMEDevice Europe, Paris - 23-24 February 2011
Dr. Xiang Zhang presented the following paper -
‘Bioceramics as Drug Carriers for Controlled Release Technology’
Abstract:
Current practice in this area is nowhere near ideal: drug admission and effectiveness of drug in action are not well controlled. New controlled release technology has been heavily investigated but the market predominantly consists of polymeric materials. However, there are certain drawbacks of polymers, such as instability of physical structure and the fact that they are not controllable at nanometre scales. This presentation will cover how these issues can be addressed with alternative drug controlled release vehicles: bioceramics. Superior characteristics of ceramics to polymers are biocompatibility, stability and, in particular, well controlled nano structure. Potential applications for targeting and long life drugs will also be discussed in the presentation.
For further details on the event, visit their website.
If you are interested in attending the Conference, please contact us for details of how you can obtain a 50% discount off the fee.
